In Brief: Vistakon
This article was originally published in The Gray Sheet
Executive Summary
Vistakon: Johnson & Johnson Vision Care Division names James Callahan as the company's new president. Callahan replaces Gary Kunkle, who resigned as president to fill another position. Callahan previously served as president of Ciba Pharmaceuticals. He was slated for the post of president of Novartis Pharmaceuticals, the U.S. company being formed by the merger of Ciba and Sandoz...
You may also be interested in...
Ciba Settles Cooper Lens Dispute; New CEO Brings Global Marketing Fluency
CooperVision will continue to sell its cosmetic contact lenses worldwide under an agreement with Ciba Vision that allows the firm to license Ciba colored contact lens patents in return for product royalties
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.